Search filters

List of works by Andrea Napolitano

A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations

scientific article published on 30 October 2018

Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression

scientific article

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs

scientific article

BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation

scientific article published on 14 June 2017

Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin

scientific article published on 6 March 2018

Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s

scientific article

Concerns About Presence of a Wild-Type BAP1 Allele in Absence of Nuclear Protein Expression

scientific article published in November 2015

Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling

scientific article

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients

scientific article published on 29 November 2010

Evaluation of clonal origin of malignant mesothelioma

scientific article

Evidence-based guidelines: Improving AGREEment on consistence evaluation

scientific article

FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model

scientific article (publication date: 15 March 2017)

Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis

scientific article published on 01 January 2020

Germline BAP1 mutations induce a Warburg effect

scientific article

HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.

scientific article published on 5 January 2016

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma

scientific article

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib

scientific article published on 29 August 2018

Improving the Accuracy of Mesothelioma Diagnosis in China

scientific article published on 19 December 2016

Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.

scientific article published on 31 July 2017

Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity

scientific article published on January 2016

Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients

scientific article published on 14 May 2022

Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies

scientific article

Malignant Mesothelioma: Time to Translate?

scientific article

Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.

scientific article

Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma

scientific article

New frontiers in the medical management of gastrointestinal stromal tumours.

scientific article published on 17 May 2019

Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas

scientific article published on 15 July 2017

PDGFRα inhibition in soft-tissue sarcomas: Have we gotten it all wrong?

scientific article published on 05 February 2019

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma

scientific article (publication date: 18 July 2016)

Preclinical development of HIvax: Human survivin highly immunogenic vaccines

scientific article published on July 2015

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab

scientific article published on 06 February 2020

Progress in the Management of Malignant Pleural Mesothelioma in 2017.

scientific article published on 7 March 2018

Recent Advances in Desmoid Tumor Therapy

scientific article published on 01 August 2020

Secondary KIT mutations: the GIST of drug resistance and sensitivity

scientific article published on 22 February 2019

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw.

scientific article published on 17 September 2012

Splicing molecular biology and novel therapies in diffuse malignant peritoneal mesothelioma

scientific article published on 03 January 2019

Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside.

scientific article published on 20 October 2011

Unexpected benefit from an 'old' metronomic chemotherapy regimen in advanced chordoma

scientific article published on 02 June 2019

Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients

scientific article published on 07 August 2019

Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives

scientific article published on June 2010

Paulina is supported by:

About Paulina

Help